Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

QL0911 for the Treatment of Cancer Treatment-Induced ThrombocytopeniaRecruiting
NCT06456528Phase 2, Phase 3Updated Sep 9, 2026
Sponsor: Qilu Pharmaceutical Co., Ltd.
Cancer Treatment-Induced Thrombocytopenia
China
Phase IIIb Study of Ribociclib + ET in Early Breast CancerRecruiting
NCT05827081Phase 3Updated Sep 9, 2026
Sponsor: Novartis Pharmaceuticals
Early Breast Cancer
United States, Argentina, Australia, Brazil, Canada +11 more
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia ARecruiting
NCT07416526Phase 3Updated Sep 9, 2026
Sponsor: Hoffmann-La Roche
Hemophilia A
United States, Argentina, Brazil, Denmark, France +10 more
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2Recruiting
NCT07431281Phase 3Updated Sep 9, 2026
Sponsor: AstraZeneca
Gastric Cancer · Gastroesophageal Junction Adenocarcinoma · Esophageal Cancer
United States, Australia, Austria, Belgium, Brazil +19 more
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)Recruiting
NCT06716606Phase 3Updated Sep 9, 2026
Sponsor: GlaxoSmithKline
Connective Tissue Diseases
United States, Argentina, Australia, China, France +6 more
ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3Recruiting
NCT06716021Phase 3Updated Sep 9, 2026
Sponsor: Milestone Pharmaceuticals Inc.
Atrial Fibrillation
United States, Canada
Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Posterior Circulation Large Vessel Occlusion StrokeRecruiting
NCT07509645Phase 3Updated Sep 9, 2026
Sponsor: Capital Medical University
Ischemic Stroke
China
Keeping RAASi Treatment With Optimal Potassium ControlRecruiting
NCT06578533Phase 3Updated Sep 9, 2026
Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia
Chronic Kidney Diseases
Spain
Adjuvant FOLFIRI Based-chemotherapy After Resection of CLM Responding to Preoperative FOLFIRIRecruiting
NCT06501482Phase 3Updated Sep 9, 2026
Sponsor: Assistance Publique - Hôpitaux de Paris
Colorectal Cancer · Colorectal Liver Metastases
France
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)Recruiting
NCT07357727Phase 3Updated Sep 9, 2026
Sponsor: Novartis Pharmaceuticals
Primary Myelofibrosis (PMF) · Post-polycythemia Vera Myelofibrosis (PPV-MF) · Post-essential Thrombocythemia Myelofibrosis (PET-MF)
United States, Argentina, Australia, China, India +7 more
Nebulized Bupivacaine Analgesia for Cleft Palate RepairRecruiting
NCT04928352Phase 3Updated Sep 9, 2026
Sponsor: Assiut University
Cleft Palate
Egypt
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body WeightRecruiting
NCT07770841Phase 3Updated Sep 9, 2026
Sponsor: Novo Nordisk A/S
Overweight · Obesity
United States, Belgium, Bulgaria, Denmark, France +5 more
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)Recruiting
NCT06997497Phase 3Updated Sep 9, 2026
Sponsor: Merck Sharp & Dohme LLC
Colon Adenocarcinoma · Rectal Adenocarcinoma
United States, Argentina, Australia, Brazil, Canada +24 more
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)Recruiting
NCT07190248Phase 3Updated Sep 9, 2026
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +25 more
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic MigraineRecruiting
NCT05711394Phase 3Updated Sep 9, 2026
Sponsor: AbbVie
Episodic Migraine
United States, Belgium, Canada, Denmark, France +11 more
Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Infants and Toddlers in ChinaRecruiting
NCT07710872Phase 3Updated Sep 9, 2026
Sponsor: Sanofi
Meningococcal Infection · Healthy Volunteers
China
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial CancerRecruiting
NCT07166094Phase 3Updated Sep 9, 2026
Sponsor: Genmab
Endometrial Cancer · Recurrent or Progressive Endometrial Cancer
United States, Australia, Belgium, Brazil, Canada +14 more
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)Recruiting
NCT06651281Phase 3Updated Sep 9, 2026
Sponsor: Merck Sharp & Dohme LLC
Crohn Disease · Colitis, Ulcerative
United States, Czechia, France, Georgia, Hungary +2 more
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFRecruiting
NCT07761117Phase 3Updated Sep 9, 2026
Sponsor: AstraZeneca
Heart Failure With Preserved Ejection Fraction (HFpEF) · Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
United States, Argentina, Australia, Austria, Brazil +27 more
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaRecruiting
NCT06948318Phase 3Updated Sep 9, 2026
Sponsor: Takeda
Immune Thrombocytopenic Purpura (ITP)
United States, Australia, Bulgaria, China, Croatia +10 more
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Recruiting
NCT04928846Phase 3Updated Sep 9, 2026
Sponsor: AbbVie
Non Small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +27 more
A 52-week Study of Remibrutinib in IgE-mediated Food AllergyRecruiting
NCT07768371Phase 3Updated Sep 9, 2026
Sponsor: Novartis Pharmaceuticals
IgE-Mediated Food Allergy · Peanut Allergy · Cow Milk Allergy · Egg Allergy
United States
A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque PsoriasisRecruiting
NCT07724366Phase 3Updated Sep 9, 2026
Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Psoriasis
China
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)Recruiting
NCT07581002Phase 2, Phase 3Updated Sep 9, 2026
Sponsor: AbbVie
Acute Myeloid Leukemia
United States, Austria, France, Israel, South Korea +2 more
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung CancerRecruiting
NCT07365241Phase 3Updated Sep 9, 2026
Sponsor: AbbVie
Small Cell Lung Cancer
United States, Austria, France, Germany, Greece +3 more

Previous page Next page